0
0
8/16/22 at 3:11pm
Organization
Pharmacytimes.com
43 words
0
Comments
A new study warns that fluoroquinolone could increase the risk of altered mental status and hospitalizations for advanced chronic kidney disease patients, though it is rare.
You are the first to view
https://www.pharmacytimes.com/view/common-antibiotic-associated-with-rare-severe-adverse-effects-for-patients-with-advanced-chronic-kidney-disease
Create an account
or login to join the discussion